{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:53:30Z","timestamp":1791359610105,"version":"4.3.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.parkreldis.2026.108949","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:33:29Z","timestamp":1787585609000},"page":"108949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Helicobacter pylori eradication status is associated with lower motor severity despite similar levodopa pharmacokinetics in Parkinson's disease"],"prefix":"10.1016","volume":"151","author":[{"given":"Haruto","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6954-591X","authenticated-orcid":false,"given":"Noriyuki","family":"Miyaue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.parkreldis.2026.108949_bib1","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1007\/s00415-010-5728-8","article-title":"Pharmacokinetics of levodopa","volume":"257","author":"Contin","year":"2010","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.parkreldis.2026.108949_bib2","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/ene.15734","article-title":"Gastrointestinal barriers to levodopa transport and absorption in parkinson's disease","volume":"30","author":"Leta","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.parkreldis.2026.108949_bib3","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.parkreldis.2026.108949_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12398","article-title":"Meta-analysis: association of Helicobacter pylori infection with Parkinson's diseases","volume":"22","author":"Shen","year":"2017","journal-title":"Helicobacter"},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108949_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1523-5378.2005.00329.x","article-title":"Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 3: predicted probability and gradients of severity of idiopathic parkinsonism based on H. pylori antibody profile","volume":"10","author":"Weller","year":"2005","journal-title":"Helicobacter"},{"issue":"12","key":"10.1016\/j.parkreldis.2026.108949_bib6","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1212\/01.wnl.0000221672.01272.ba","article-title":"Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations","volume":"66","author":"Pierantozzi","year":"2006","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.parkreldis.2026.108949_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112330","article-title":"Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease","volume":"9","author":"Hashim","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.parkreldis.2026.108949_bib8","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1007\/s00415-013-7089-6","article-title":"Motor fluctuations and Helicobacter pylori in Parkinson's disease","volume":"260","author":"Rahne","year":"2013","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108949_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-023-00404-1","article-title":"Helicobacter pylori infection and Parkinson's disease: etiology, pathogenesis and levodopa bioavailability","volume":"21","author":"Wei","year":"2024","journal-title":"Immun. Ageing"},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108949_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.34172\/mejdd.2022.261","article-title":"Evaluation of inflammatory cytokine and anti Helicobacter Pylori antibodies in the pathogenesis of Parkinson's Disease","volume":"14","author":"Shamsdin","year":"2022","journal-title":"Middle East J. Dig. Dis."},{"key":"10.1016\/j.parkreldis.2026.108949_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123202","article-title":"Effect of concomitant use of esomeprazole on levodopa pharmacokinetics and clinical symptoms in patients with Parkinson's disease","volume":"465","author":"Miyaue","year":"2024","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2026.108949_bib12","article-title":"Concomitant use of magnesium oxide significantly decreases absorption of levodopa preparations in patients with Parkinson's disease","volume":"9","author":"Miyaue","year":"2023","journal-title":"Clin. Park. Relat. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2026.108949_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/mdc3.12921","article-title":"Levodopa equivalent dose conversion factors: an updated proposal including opicapone and safinamide","volume":"7","author":"Schade","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"2","key":"10.1016\/j.parkreldis.2026.108949_bib14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00415-021-10473-1","article-title":"Helicobacter pylori infection is associated with a poor response to levodopa in patients with Parkinson's disease: a systematic review and meta-analysis","volume":"269","author":"Zhong","year":"2022","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2026.108949_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.parkreldis.2014.12.009","article-title":"Helicobacter pylori infection is associated with worse severity of Parkinson's disease","volume":"21","author":"Tan","year":"2015","journal-title":"Park. Relat. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108949_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/WNF.0000000000000037","article-title":"Pharmacokinetics of levodopa in patients with Parkinson disease and motor fluctuations depending on the presence of Helicobacter pylori infection","volume":"37","author":"Naro\u017ca\u0144ska","year":"2014","journal-title":"Clin. Neuropharmacol."},{"issue":"12","key":"10.1016\/j.parkreldis.2026.108949_bib17","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.parkreldis.2015.10.006","article-title":"Minimal clinically important difference on the motor examination part of MDS-UPDRS","volume":"21","author":"Horv\u00e1th","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2026.108949_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.clineuro.2017.07.003","article-title":"Eradication of Helicobacter pylori infection might improve clinical status of patients with Parkinson's disease, especially on bradykinesia","volume":"160","author":"Liu","year":"2017","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108949_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153725","article-title":"Augmentation of autoantibodies by Helicobacter pylori in Parkinson's disease patients may be linked to greater severity","volume":"11","author":"Suwarnalata","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2026.108949_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4807179","article-title":"Chronic systemic inflammation exacerbates neurotoxicity in a Parkinson's disease model","volume":"2020","author":"Ugalde-Mu\u00f1iz","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.parkreldis.2026.108949_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009836","article-title":"Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome","volume":"5","author":"Jakobsson","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.parkreldis.2026.108949_bib22","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.parkreldis.2026.108949_bib23","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in Parkinson's disease","volume":"30","author":"Keshavarzian","year":"2015","journal-title":"Mov. Disord."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026007765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026007765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:34:45Z","timestamp":1791358485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802026007765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":23,"alternative-id":["S1353802026007765"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108949","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Helicobacter pylori eradication status is associated with lower motor severity despite similar levodopa pharmacokinetics in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108949"}}